Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
RadNet provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $1.4B | $1.6B | $1.8B | $2.0B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $35.7M | $82.6M | $46.4M | $98.7M | $104.6M | $62.0M |
| Net income | -$14.8M | $24.7M | $10.7M | $3.0M | $2.8M | -$18.6M |
| Diluted EPS | -$0.29 | $0.46 | $0.17 | $0.05 | $0.04 | -$0.25 |
| Operating cash flow | $233.8M | $149.5M | $146.4M | $220.9M | $233.0M | $298.8M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 3.3% | 6.3% | 3.2% | 6.1% | 5.7% | 3.0% |
| Net margin | -1.4% | 1.9% | 0.7% | 0.2% | 0.2% | -0.9% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $459.7M | $461.1M | $477.1M | $471.4M | $498.2M | $522.9M | $547.7M | $575.6M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $34.8M | $33.9M | $24.5M | -$24.1M | $30.9M | $27.4M | $27.8M | -$23.9M |
| Net income | -$3.0M | $3.2M | $5.3M | -$37.9M | $14.5M | $5.4M | -$595,000.00 | -$33.5M |
| Diluted EPS | -$0.04 | $0.04 | $0.08 | -$0.51 | $0.19 | $0.07 | $0.00 | -$0.43 |
| Operating cash flow | $116.0M | $57.4M | $42.5M | $41.5M | $120.3M | $52.8M | $84.2M | $79.0M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 7.6% | 7.4% | 5.1% | -5.1% | 6.2% | 5.2% | 5.1% | -4.2% |
| Net margin | -0.6% | 0.7% | 1.1% | -8.0% | 2.9% | 1.0% | -0.1% | -5.8% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-18 | SWARTZ DAVID L | Sale | 2,699 | $53.89 | $145,449.11 | filing |
| 2026-06-16 | Wesdorp Cornelis· Pres & CEO, Digital Health | Sale | 4,750 | $58.11 | $276,022.50 | filing |
| 2026-06-16 | BERGER HOWARD G· President, CEO | Gift | 90 | $0.00 | $0.00 | filing |
| 2026-06-15 | Forthuber Stephen M· Pres & CEO-Eastern Operations | Sale | 24,214 | $57.79 | $1.4M | filing |
| 2026-06-15 | Forthuber Stephen M· Pres & CEO-Eastern Operations | Sale | 19,853 | $58.61 | $1.2M | filing |
| 2026-06-02 | SWARTZ DAVID L | Award | 2,946 | $0.00 | $0.00 | filing |
| 2026-06-02 | SPURLOCK GREGORY E. | Award | 2,946 | $0.00 | $0.00 | filing |
| 2026-06-02 | Jacobs Laura Pastre | Award | 2,946 | $0.00 | $0.00 | filing |
| 2026-06-02 | Levitt Lawrence L | Award | 2,946 | $0.00 | $0.00 | filing |
| 2026-05-05 | BERGER HOWARD G· President, CEO | Option exercise | 25,992 | $18.64 | $484,490.88 | filing |
| 2026-03-19 | Unknown· Chief Strategy Officer | Sale | 9,554 | $61.84 | $590,819.36 | filing |
| 2026-03-19 | Unknown· Chief Strategy Officer | Sale | 5,346 | $62.82 | $335,835.72 | filing |
| 2026-03-19 | Unknown· Chief Strategy Officer | Sale | 100 | $63.59 | $6,359.00 | filing |
| 2026-03-19 | Unknown· Chief Strategy Officer | Gift | 7,000 | $0.00 | $0.00 | filing |
| 2026-03-18 | Unknown· Chief Strategy Officer | Sale | 14,200 | $62.12 | $882,104.00 | filing |
| 2026-03-18 | Unknown· Chief Strategy Officer | Sale | 800 | $62.72 | $50,176.00 | filing |
| 2026-03-16 | Unknown· Chief Strategy Officer | Tax withholding | 5,919 | $61.72 | $365,320.68 | filing |
| 2026-03-10 | Unknown· Chief Strategy Officer | Option exercise | 3,742 | $0.00 | $0.00 | filing |
| 2026-03-10 | Unknown· Chief Strategy Officer | Option exercise | 4,987 | $0.00 | $0.00 | filing |
| 2026-03-10 | Unknown· Chief Strategy Officer | Option exercise | 6,237 | $0.00 | $0.00 | filing |
| 2026-03-10 | Unknown· Chief Strategy Officer | Option exercise | 7,481 | $0.00 | $0.00 | filing |
| 2026-03-10 | Unknown· Chief Strategy Officer | Option exercise | 8,727 | $0.00 | $0.00 | filing |
| 2026-03-10 | Unknown· Chief Strategy Officer | Option exercise | 12,466 | $0.00 | $0.00 | filing |
| 2026-03-10 | Unknown· Chief Strategy Officer | Option exercise | 2,493 | $0.00 | $0.00 | filing |
| 2026-03-10 | Unknown· Chief Strategy Officer | Option exercise | 16,831 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.